|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Vesanoid (Tretinoin Oral). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (21)
Cases resulting in a serious event (21)
Cases resulting in death (6)
Cases resulting in life threatening events (2)
Cases resulting in hospitalization (9)
Cases resulting in disability (1)
Cases resulting in other serious reactions (7)
Adverse event in 65 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Japan on 2007-10-31
Patient: 65 year old male, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Pulmonary Alveolar Haemorrhage
Adverse event resulted in: death
Suspect drug(s):
Vesanoid
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2007-07-09
End date: 2007-07-10
Gran
Dosage: route: injectable (not otherwise specified). generic name: filgrastim (genetical recombination).
Indication: Drug USE FOR Unknown Indication
Start date: 2007-07-06
End date: 2007-07-10
Other drugs received by patient: Cylocide; Idamycin; Diflucan; Radicut
Adverse event in 65 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Japan on 2007-10-26
Patient: 65 year old male, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Pulmonary Alveolar Haemorrhage
Adverse event resulted in: death
Suspect drug(s):
Vesanoid
Dosage: 30mg in the daytime, 20 mg in the evening
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2007-07-09
End date: 2007-07-09
Vesanoid
Administration route: Oral
Start date: 2007-07-10
End date: 2007-07-10
Gran
Dosage: route: injectable (not otherwise specified). generic name: filgrastim (genetical recombination).
Indication: Drug USE FOR Unknown Indication
Start date: 2007-07-06
End date: 2007-07-10
Other drugs received by patient: Cylocide; Idamycin; Diflucan
Adverse event in 69 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Japan on 2007-10-26
Patient: 69 year old male
Adverse reactions / side effects: Retinoic Acid Syndrome, Pulmonary Alveolar Haemorrhage
Suspect drug(s):
Vesanoid (Tretinoin Oral)
Adverse event in 65 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Japan on 2007-10-16
Patient: 65 year old male, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Respiratory Failure, Pulmonary Alveolar Haemorrhage
Adverse event resulted in: death
Suspect drug(s):
Vesanoid
Dosage: 30mg in the daytime, 20 mg in the evening
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Start date: 2007-07-09
End date: 2007-07-09
Vesanoid
Administration route: Oral
Start date: 2007-07-10
End date: 2007-07-10
Gran
Dosage: route: injectable (not otherwise specified). generic name: filgrastim (genetical recombination).
Indication: Drug USE FOR Unknown Indication
Start date: 2007-07-05
Other drugs received by patient: Cylocide; Idamycin; Diflucan
Adverse event in 34 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a pharmacist from United States on 2007-10-10
Patient: 34 year old male, weighing 61.2 kg (134.6 pounds)
Adverse reactions / side effects: Heart Rate Decreased, Cardio-Respiratory Arrest, Blood Pressure Decreased
Adverse event resulted in: death
Suspect drug(s):
Vesanoid (Tretinoin Oral)
Adverse event in 68 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Japan on 2007-07-20
Patient: 68 year old male, weighing 100.0 kg (220.0 pounds)
Adverse reactions / side effects: Respiratory Failure, Cardiac Failure, Interstitial Lung Disease
Suspect drug(s):
Vesanoid (Tretinoin Oral)
Other drugs received by patient: Idamycin; FOY; Cylocide
Adverse event in female receiving Vesanoid (Tretinoin Oral)
Reported by a pharmacist from United Kingdom on 2007-07-16
Patient: female
Adverse reactions / side effects: Dysphagia
Adverse event resulted in: hospitalization
Suspect drug(s):
Vesanoid (Tretinoin Oral)
Adverse event in 19 year old female receiving Vesanoid (Tretinoin Oral)
Reported by a pharmacist from United States on 2007-06-14
Patient: 19 year old female, weighing 74.5 kg (163.9 pounds)
Adverse reactions / side effects: Abortion Spontaneous
Suspect drug(s):
Vesanoid
Dosage: 40 mg every 12 hours
Start date: 2007-04-12
End date: 2007-04-13
Vesanoid
Start date: 2007-04-22
End date: 2007-04-23
Other drugs received by patient: Idarubicin HCL
Adverse event in 19 year old female receiving Vesanoid (Tretinoin Oral)
Reported by a pharmacist from United States on 2007-06-13
Patient: 19 year old female, weighing 74.5 kg (163.9 pounds)
Adverse reactions / side effects: Retinoic Acid Syndrome, Respiratory Failure, Disseminated Intravascular Coagulation, Hypoxia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Vesanoid
Start date: 2007-04-22
End date: 2007-04-23
Vesanoid
Dosage: 40mg every 12 hours
Start date: 2007-04-12
End date: 2007-04-13
Other drugs received by patient: Idarubicin HCL
Adverse event in 19 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Japan on 2007-06-04
Patient: 19 year old male, weighing 57.2 kg (125.8 pounds)
Adverse reactions / side effects: Histiocytosis Haematophagic
Adverse event resulted in: disablity
Suspect drug(s):
Vesanoid
Administration route: Oral
Start date: 2002-06-27
End date: 2002-07-10
Vesanoid
Administration route: Oral
Start date: 2002-07-23
Other drugs received by patient: FOY; Futhan; Modacin; Tobracin; Zantac; Diflucan; Levofloxacin; Idarubicin HCL
Adverse event in 27 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Brazil on 2007-05-15
Patient: 27 year old male
Adverse reactions / side effects: Retinoic Acid Syndrome, Dyspnoea, Rhabdomyolysis, Blood Lactate Dehydrogenase Increased, Hypotension, Pyrexia, Transaminases Increased, Renal Failure Acute
Suspect drug(s):
Vesanoid (Tretinoin Oral)
Other drugs received by patient: Daunorubicin HCL; Cytarabine
Adverse event in 19 year old female receiving Vesanoid (Tretinoin Oral)
Reported by a pharmacist from United States on 2007-05-14
Patient: 19 year old female
Adverse reactions / side effects: Respiratory Failure
Adverse event resulted in: hospitalization
Suspect drug(s):
Vesanoid (Tretinoin Oral)
Adverse event in 45 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Canada on 2007-04-06
Patient: 45 year old male, weighing 114.0 kg (250.8 pounds)
Adverse reactions / side effects: Leukoencephalopathy, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Vesanoid
Administration route: Oral
Start date: 2006-11-22
End date: 2006-11-23
Vesanoid
Administration route: Oral
Start date: 2006-11-27
End date: 2007-01-12
Vesanoid
Administration route: Oral
Start date: 2007-01-29
Other drugs received by patient: Idamycin; Acyclovir; Acyclovir; Voriconazole; Voriconazole; Voriconazole
Adverse event in 38 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from United States on 2007-04-04
Patient: 38 year old male
Adverse reactions / side effects: Primary Hypothyroidism, Congenital Endocrine Anomaly
Suspect drug(s):
Vesanoid
Dosage: the patient was scheduled to take vesanoid for a total of 1 year. he was in his 3rd or 4th round a+
Start date: 2006-09-15
Vesanoid
Dosage: vesanoid was decreased to '2 cap bid x 15 days q 3 months x 1 year.'
Adverse event in 11 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Japan on 2007-03-12
Patient: 11 year old male, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Retinoic Acid Syndrome, Haemorrhage Intracranial
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Vesanoid (Tretinoin Oral)
Other drugs received by patient: Cytarabine; Daunorubicin HCL; Allopurinol; Baktar; Kytril
Adverse event in 38 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from United States on 2007-02-23
Patient: 38 year old male
Adverse reactions / side effects: Primary Hypothyroidism, Generalised Resistance TO Thyroid Hormone
Suspect drug(s):
Vesanoid (Tretinoin Oral)
Adverse event in 60 year old female receiving Vesanoid (Tretinoin Oral)
Reported by a health professional (non-physician/pharmacist) from France on 2007-02-23
Patient: 60 year old female, weighing 68.0 kg (149.6 pounds)
Adverse reactions / side effects: Pneumonia, Hepatic Function Abnormal, Respiratory Disorder, Haemoptysis, Alanine Aminotransferase Increased, Pneumocystis Jiroveci Infection, Hepatic Enzyme Increased, Retinoic Acid Syndrome, Weight Increased, Interstitial Lung Disease, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Hypoxia, Pleural Effusion, Pancreatic Enzymes Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Dexrazoxane Hydrochloride Powder, Sterile
Indication: Acute Myeloid Leukaemia
Start date: 2006-08-22
End date: 2006-08-24
Cytarabine
Indication: Acute Myeloid Leukaemia
Start date: 2006-08-22
End date: 2006-08-28
Daunorubicin HCL
Indication: Acute Myeloid Leukaemia
Start date: 2006-08-22
End date: 2006-08-24
Primperan
Indication: Nausea
Primperan
Indication: Vomiting
Zofran
Dosage: text:2 df
Indication: Nausea
Start date: 2006-08-22
End date: 2006-09-05
Zofran
Indication: Vomiting
Vesanoid
Dosage: daily dose:80mg
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2006-08-18
End date: 2006-09-05
Other drugs received by patient: Ranitidine; Bromazepam; Acetaminophen; Amphotericin B; Ranitidine Hydrochloride
Adverse event in 45 year old male receiving Vesanoid (Tretinoin Oral)
Reported by a physician from Canada on 2007-02-20
Patient: 45 year old male, weighing 114.0 kg (250.8 pounds)
Adverse reactions / side effects: Leukoencephalopathy, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Vesanoid
Administration route: Oral
Start date: 2006-11-27
End date: 2007-01-12
Vesanoid
Administration route: Oral
Start date: 2007-01-29
Other drugs received by patient: Idamycin; Acyclovir; Acyclovir; Voriconazole; Voriconazole
Adverse event in receiving Vesanoid (Tretinoin Oral)
Reported by a pharmacist from Canada on 2007-01-30
Patient:
Adverse reactions / side effects: Progressive Multifocal Leukoencephalopathy
Suspect drug(s):
Vesanoid (Tretinoin Oral)
Adverse event in 60 year old female receiving Vesanoid (Tretinoin Oral)
Reported by a consumer/non-health professional from France on 2007-01-25
Patient: 60 year old female, weighing 68.0 kg (149.6 pounds)
Adverse reactions / side effects: Pneumonia, Haemoptysis, Hepatic Enzyme Increased, Liver Disorder, Weight Increased, Pneumocystis Jiroveci Pneumonia, Gamma-Glutamyltransferase Increased, Hypoxia, Pleural Effusion, Pancreatic Enzymes Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Vesanoid
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2006-08-18
End date: 2006-09-05
Cardioxane
Start date: 2006-08-22
End date: 2006-08-24
Zofran
Dosage: 2 doses taken every day.
Indication: Vomiting
Start date: 2006-08-22
End date: 2006-09-05
Primperan
Indication: Vomiting
End date: 2006-08-29
Cerubidine
Start date: 2006-08-22
End date: 2006-08-24
Aracytine
Start date: 2006-08-22
End date: 2006-08-28
Adverse event in 60 year old female receiving Vesanoid (Tretinoin Oral)
Reported by a consumer/non-health professional from France on 2007-01-25
Patient: 60 year old female, weighing 68.0 kg (149.6 pounds)
Adverse reactions / side effects: Dyspnoea, Pneumonia, Haemoptysis, Transaminases Increased, Weight Increased, Retinoic Acid Syndrome, Interstitial Lung Disease, Gamma-Glutamyltransferase Increased, Pleural Effusion, Tachypnoea, Pancreatic Enzymes Increased, Cough, Oxygen Saturation Decreased, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Zofran
Dosage: 2inj per day
Indication: Vomiting
Start date: 2006-08-22
End date: 2006-09-05
Aracytine
Dosage: 350mg per day
Indication: Acute Myeloid Leukaemia
Start date: 2006-08-22
End date: 2006-08-28
Cerubidine
Dosage: 110mg per day
Indication: Acute Myeloid Leukaemia
Start date: 2006-08-22
End date: 2006-08-24
Primperan
Indication: Vomiting
Start date: 2006-08-18
End date: 2006-08-29
Cardioxane
Dosage: 2g per day
Indication: Acute Myeloid Leukaemia
Start date: 2006-08-22
End date: 2006-08-24
Vesanoid
Dosage: 80mg per day
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2006-08-18
End date: 2006-09-05
Other drugs received by patient: Zantac; Lexomil; Perfalgan; Fungizone; Heparin; Spasfon
|
